Protective cardiorenal effects of spironolactone in a rodent model of polycystic kidney disease

E-ISSN： 1440-1681|42|4|353-360

ISSN： 0305-1870

Source： CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol.42, Iss.4, 2015-04, pp. : 353-360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Practical Genetics for Autosomal Dominant Polycystic Kidney Disease

Nephron Clin Pract, Vol. 118, Iss. 1, 2010-11 ,pp. : c19-c30

Karger

Access to resources Recommend Favorite

Systems biology of polycystic kidney disease: a critical review

WILEY INTERDISCIPLINARY REVIEWS: SYSTEMS BIOLOGY AND MEDICINE (ELECTRONIC), Vol. 7, Iss. 1, 2015-01 ,pp. : 39-52

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic Advances in the Treatment of Polycystic Kidney Disease

Nephron Clin Pract, Vol. 128, Iss. 3-4, 2015-0 ,pp. : 297-302

Karger

Access to resources Recommend Favorite

Retroperitoneoscopic Managementof Infected Cysts in Adult Polycystic Kidney Disease

Urologia Internationalis, Vol. 62, Iss. 1, 1999-07 ,pp. : 40-43

Karger

Access to resources Recommend Favorite

Retroperitoneoscopic Nephrectomy for Autosomal Dominant Polycystic Kidney Disease: Initial Experience

Urologia Internationalis, Vol. 79, Iss. 2, 2007-09 ,pp. : 137-141

Karger

Access to resources Recommend Favorite